Home > Insider Trading > Filing (0000899243-21-018013)

Filing Details

Accession Number:: 0000899243-21-018013
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-05-04 13:00:00
Reporting Period:: 2021-04-30

Accepted Time:: 2021-05-04 11:00:40
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1719395	Eargo Inc.	EAR	Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)	273879804

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1756338	Geoff Pardo	C/O Gilde Healthcare Partners 222 Third Street, Suite 1321 Cambridge MA 02142		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-04-30	24,995	$56.16	3,098,227	No	4	S	Indirect	See footnote
Common Stock	Disposition	2021-04-30	54,586	$56.84	3,043,641	No	4	S	Indirect	See footnote
Common Stock	Disposition	2021-04-30	24,950	$57.53	3,018,691	No	4	S	Indirect	See footnote
Common Stock	Disposition	2021-05-03	17,834	$54.37	3,000,857	No	4	S	Indirect	See footnote
Common Stock	Disposition	2021-05-03	1,558	$55.36	2,999,299	No	4	S	Indirect	See footnote
Common Stock	Disposition	2021-05-03	2,163	$56.65	2,997,136	No	4	S	Indirect	See footnote
Common Stock	Disposition	2021-05-03	450	$57.14	2,996,686	No	4	S	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $55.38 to $56.37, inclusive. The Reporting Person undertakes to provide to Eargo, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
These shares are held directly by Cooperatieve Gilde Healthcare V U.A. ("Gilde"). Gilde is managed by Gilde Healthcare V Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. The Reporting Person is a partner of Gilde. The reporting person disclaims beneficial ownership of all applicable shares except to the extent of his actual pecuniary interest in such shares.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $56.38 to $57.37, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $57.38 to $57.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $53.95 to $54.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $55.00 to $55.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $56.13 to $57.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.